A human neuroblastoma xenograft model for [131I]-metaiodobenzylguanidine (MIBG) biodistribution and targeted radiotherapy
Rutgers, M.; Gubbels, A.A.; Hoefnagel, C.A.; Voûte, P.A.; Smets, L.A.
Progress in Clinical and Biological Research 366: 471-478
1991
ISSN/ISBN: 0361-7742 PMID: 2068162 Document Number: 377297
Document emailed within 1 workday
Related Documents
Liu, B.; Zhuang, H.; Servaes, S. 2013: Comparison of [123I]MIBG and [131I]MIBG for imaging of neuroblastoma and other neural crest tumors Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 57(1): 21-28Cui, H. 1990: Biodistribution, pharmacokinetics and imaging of 131I-labeled HMD4 human McAb in human ovarian carcinoma xenograft in nude mice Zhonghua Fu Chan Ke Za Zhi 25(2): 80
Iavarone, A.; Lasorella, A.; Servidei, T.; Riccardi, R.; Troncone, L.; Mastrangelo, R. 1991: Biology of metaiodobenzylguanidine interactions with human neuroblastoma cells Journal of Nuclear Biology and Medicine 35(4): 186-190
Montaldo, P.G.; Carbone, R.; Lanciotti, M.; Ponzoni, M.; Cornaglia-Ferraris, P. 1991: In vitro pharmacology of metaiodobenzylguanidine uptake, storage and release in human neuroblastoma cells Journal of Nuclear Biology and Medicine 35(4): 195-198
Houghton, A.; Clarke, S.; Jourdan, M. 1990: False-positive diagnosis of adrenal phaeochromocytoma on metaiodobenzylguanidine (MIBG) [correction of MIGB] scan British Journal of Clinical Practice 44(10): 411-412
Lode, H.N.; Reisfeld, R.A.; Handgretinger, R.; Nicolaou, K.C.; Gaedicke, G.; Wrasidlo, W. 1998: Targeted therapy with a novel enediyene antibiotic calicheamicin theta(I)1 effectively suppresses growth and dissemination of liver metastases in a syngeneic model of murine neuroblastoma Cancer Research 58(14): 2925-2928
Troncone, L.; Rufini, V.; Riccardi, R.; Lasorella, A.; Mastrangelo, R. 1991: The use of [131I]metaiodobenzylguanidine in the treatment of neuroblastoma after conventional therapy Journal of Nuclear Biology and Medicine 35(4): 232-236
Tsuchimochi, S.; Nakajo, M.; Nakabeppu, Y.; Tani, A. 1997: Metastatic pulmonary pheochromocytomas: positive I-123 MIBG SPECT with negative I-131 MIBG and equivocal I-123 MIBG planar imaging Clinical Nuclear Medicine 22(10): 687-690
Aktolun, C.; Castellani, M.R. 2013: Theranostic role of MIBG in neuroblastoma Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 57(1): 3-5
Klingebiel, T.; Feine, U.; Treuner, J.; Reuland, P.; Handgretinger, R.; Niethammer, D. 1991: Treatment of neuroblastoma with [131I]metaiodobenzylguanidine: long-term results in 25 patients Journal of Nuclear Biology and Medicine 35(4): 216-219
Andrich, M.P.; Shalaby-Rana, E.; Movassaghi, N.; Majd, M. 1996: The role of 131 iodine-metaiodobenzylguanidine scanning in the correlative imaging of patients with neuroblastoma Pediatrics 97(2): 246-250
O'Donoghue, J.A.; Wheldon, T.E.; Babich, J.W.; Moyes, J.S.; Barrett, A.; Meller, S.T. 1991: Therapeutic implications of the uptake of radiolabelled mIBG for the treatment of neuroblastoma Progress in Clinical and Biological Research 366: 455-461
Van der Jagt, R.H.; Badger, C.C.; Appelbaum, F.R.; Press, O.W.; Matthews, D.C.; Eary, J.F.; Krohn, K.A.; Bernstein, I.D. 1992: Localization of radiolabeled antimyeloid antibodies in a human acute leukemia xenograft tumor model Cancer Research 52(1): 89-94
Kawamura, T.; Endo, Y.; Yonemura, Y.; Nojima, N.; Fujita, H.; Fujimura, T.; Obata, T.; Yamaguchi, T.; Sasaki, T. 2001: Significance of integrin alpha2/beta1 in peritoneal dissemination of a human gastric cancer xenograft model International Journal of Oncology 18(4): 809-815
Perez-Polo, J.R.; Reynolds, C.P.; Tiffany-Castiglioni, E.; Ziegler, M.; Schulze, I.; Werrback-Perez, K. 1982: NGF effects on human neuroblastoma lines: a model system Progress in Clinical and Biological Research 79: 285-299
Link, E.M.; Carpenter, R.N. 1992: 211At-methylene blue for targeted radiotherapy of human melanoma xenografts: treatment of cutaneous tumors and lymph node metastases Cancer Research 52(16): 4385-4390
Kocheril, S.V.; Grignon, D.J.; Wang, C.Y.; Maughan, R.L.; Montecillo, E.J.; Talati, B.; Tekyi-Mensah, S.; Pontes, J.e.; Hillman, G.G. 1999: Responsiveness of human prostate carcinoma bone tumors to interleukin-2 therapy in a mouse xenograft tumor model Cancer Detection and Prevention 23(5): 408-416
Jurd, K.M.; Lee, J.; Cairns, T.; Hunt, B.J. 1996: Effect of Gal alpha 1,3 Gal-beta 1,4 GlcNAc and complement depletion on haemostatic activation in an in vitro model of the pig-to-human xenograft reaction Transplantation Proceedings 28(2): 637-638
Higgins, B.; Kolinsky, K.; Linn, M.; Adames, V.; Zhang, Y-E.; Moisa, C.; Dugan, U.; Heimbrook, D.; Packman, K. 2007: Antitumor activity of capecitabine and bevacizumab combination in a human estrogen receptor-negative breast adenocarcinoma xenograft model Anticancer Research 27(4b): 2279-2287
Lumbroso, J.D.; Guermazi, F.; Hartmann, O.; Coornaert, S.; Rabarison, Y.; Leclère, J.G.; Couanet, D.; Bayle, C.; Caillaud, J.M.; Lemerle, J. 1988: Meta-iodobenzylguanidine (mIBG) scans in neuroblastoma: sensitivity and specificity, a review of 115 scans Progress in Clinical and Biological Research 271: 689-705